Latest Market News

The Brazilian government has imposed a 12% tax on crude oil exports effective immediately, a move framed as windfall profit sharing amid high oil prices. Karoon Energy, with significant Brazilian operations, faces new cost pressures as the tax awaits potential ratification by Congress.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

OzAurum Resources has kicked off an 18,000-metre drilling campaign at its Mulgabbie North Gold Project, aiming to confirm high-grade gold zones and accelerate its pathway to production.

ADX Energy has secured A$4.4 million through a well-supported placement to fund key exploration projects in Austria and Italy, alongside plans for a strategic dual listing on Oslo Børs’ Euronext Growth market.

Forte Energy has completed a major acquisition of oil leases in Alaska’s National Petroleum Reserve, with technical work underway on the promising Harrier Prospect and cost-saving lease fee suspensions boosting near-term flexibility.

Quantum Graphite’s partner Sunlands Pure Group has signed a key MOU with Oman’s Al Buraimi Governorate to develop a large-scale graphite refinery, positioning Quantum as the exclusive graphite supplier for global battery and energy markets.

H3 Energy has appointed LAB Energy Advisors to spearhead farm-in talks for its Alinya project, a vast and underexplored oil and gas prospect in South Australia’s Officer Basin. The move aims to accelerate partner engagement ahead of drilling a potentially game-changing well.

Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.

Immutep Limited has discontinued its pivotal TACTI-004 Phase III trial in first-line non-small cell lung cancer following an independent futility analysis, prompting a strategic reassessment of its clinical program and finances.

dorsaVi has initiated early-stage evaluation of resistive RAM (RRAM) test chips, marking a key step toward an advanced 22-nm memory platform designed to meet rising AI-driven demands in edge computing.

Collins Foods has agreed to settle a class action over employee 10-minute rest breaks for up to AUD 9 million, pending Federal Court approval. The settlement includes flexible terms based on participant numbers, with no admission of liability.